These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 14559113
1. Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Chatterjee SN, Chaudhuri K. Biochim Biophys Acta; 2003 Oct 15; 1639(2):65-79. PubMed ID: 14559113 [Abstract] [Full Text] [Related]
2. Lipopolysaccharides of Vibrio cholerae II. Genetics of biosynthesis. Chatterjee SN, Chaudhuri K. Biochim Biophys Acta; 2004 Oct 14; 1690(2):93-109. PubMed ID: 15469898 [Abstract] [Full Text] [Related]
3. Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal. Knirel YA, Widmalm G, Senchenkova SN, Jansson PE, Weintraub A. Eur J Biochem; 1997 Jul 01; 247(1):402-10. PubMed ID: 9249053 [Abstract] [Full Text] [Related]
4. Biological activities of lipopolysaccharide isolated from Vibrio cholerae O139, a new epidemic strain for recent cholera in Indian subcontinent. Shimizu T, Yanagihara Y, Isshiki Y, Kawamata Y, Kondo S, Hisatsune K. Microbiol Immunol; 1994 Jul 01; 38(6):471-4. PubMed ID: 7968678 [Abstract] [Full Text] [Related]
5. Epidemiology & molecular biology of Vibrio cholerae O139 Bengal. Albert MJ. Indian J Med Res; 1996 Jul 01; 104():14-27. PubMed ID: 8783504 [Abstract] [Full Text] [Related]
6. More on the structure of Vibrio cholerae O22 lipopolysaccharide. Knirel YA, Senchenkova SN, Jansson PE, Weintraub A. Carbohydr Res; 1998 Aug 01; 310(1-2):117-9. PubMed ID: 9794075 [Abstract] [Full Text] [Related]
7. Structural analysis of the lipopolysaccharide from Vibrio cholerae O139. Cox AD, Brisson JR, Varma V, Perry MB. Carbohydr Res; 1996 Aug 26; 290(1):43-58. PubMed ID: 8805781 [Abstract] [Full Text] [Related]
8. O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent. Hisatsune K, Kondo S, Isshiki Y, Iguchi T, Kawamata Y, Shimada T. Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1309-15. PubMed ID: 7504475 [Abstract] [Full Text] [Related]
10. Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin. Kossaczka Z, Szu SC. Glycoconj J; 2000 Jun 15; 17(6):425-33. PubMed ID: 11294508 [Abstract] [Full Text] [Related]
11. Characterizing lipopolysaccharide and core lipid A mutant O1 and O139 Vibrio cholerae strains for adherence properties on mucus-producing cell line HT29-Rev MTX and virulence in mice. Schild S, Lamprecht AK, Fourestier C, Lauriano CM, Klose KE, Reidl J. Int J Med Microbiol; 2005 Aug 15; 295(4):243-51. PubMed ID: 16128399 [Abstract] [Full Text] [Related]
12. An immunochemical study of serological cross-reaction between lipopolysaccharides from Vibrio cholerae O22 and O139. Isshiki Y, Kondo S, Iguchi T, Sano Y, Shimada T, Hisatsune K. Microbiology (Reading); 1996 Jun 15; 142 ( Pt 6)():1499-1504. PubMed ID: 8704989 [Abstract] [Full Text] [Related]
13. A comparative study of the properties of Vibrio cholerae O139, O1 and other non-O1 strains. Nandy RK, Sengupta TK, Mukhopadhyay S, Ghose AC. J Med Microbiol; 1995 Apr 15; 42(4):251-7. PubMed ID: 7707332 [Abstract] [Full Text] [Related]
14. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Waldor MK, Colwell R, Mekalanos JJ. Proc Natl Acad Sci U S A; 1994 Nov 22; 91(24):11388-92. PubMed ID: 7972070 [Abstract] [Full Text] [Related]
15. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand. Siriphap A, Leekitcharoenphon P, Kaas RS, Theethakaew C, Aarestrup FM, Sutheinkul O, Hendriksen RS. PLoS One; 2017 Nov 22; 12(1):e0169324. PubMed ID: 28103259 [Abstract] [Full Text] [Related]
16. Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide. Attridge SR, Wallerström G, Li BL, Morona R, Holmgren J. Vaccine; 2009 Feb 11; 27(7):1055-61. PubMed ID: 19100303 [Abstract] [Full Text] [Related]
17. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of Vibrio cholerae O1 from Phage-Displayed Human Synthetic Fab Library. Kim D, Hong J, Choi Y, Han J, Kim S, Jo G, Yoon JY, Chae H, Yoon H, Lee C, Hong HJ. J Microbiol Biotechnol; 2020 Nov 28; 30(11):1760-1768. PubMed ID: 32876069 [Abstract] [Full Text] [Related]
18. The O polysaccharide chain of the lipopolysaccharide from Vibrio cholerae O76 is a homopolymer of N-[(S)-(+)-2-hydroxypropionyl]-alpha-L-perosamine. Kondo S, Sano Y, Isshiki Y, Hisatsune K. Microbiology (Reading); 1996 Oct 28; 142 ( Pt 10)():2879-85. PubMed ID: 8885404 [Abstract] [Full Text] [Related]
19. Vibrio cholerae O139 capsular polysaccharide confers complement resistance in the absence or presence of antibody yet presents a productive target for cell lysis: implications for detection of bactericidal antibodies. Attridge SR, Holmgren J. Microb Pathog; 2009 Dec 28; 47(6):314-20. PubMed ID: 19818394 [Abstract] [Full Text] [Related]
20. Electrophoretic mobility and immune response of outer membrane proteins of Vibrio cholerae O139. Pal S, Sasmal D, Guhathakurta B, Nair GB, Bhattacharya SK, Mallick R, Datta A. FEMS Immunol Med Microbiol; 1996 Sep 28; 15(2-3):143-8. PubMed ID: 8880140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]